Inscription Capital’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.82M Sell
46,579
-3,568
-7% -$145K 0.19% 90
2025
Q4
$2.05M Buy
50,147
+3,222
+7% +$131K 0.21% 77
2025
Q3
$1.89M Buy
46,925
+7,526
+19% +$290K 0.2% 76
2025
Q2
$1.45M Buy
+39,399
New +$1.33M 0.21% 77

Other funds holding RECS

Inscription Capital's RECS Position: Q1 2026 in Review

Inscription Capital reduced its Columbia Research Enhanced Core ETF (RECS) stake by 7.1% in Q1 2026, selling an estimated $145K and leaving 46,579 shares worth $1.82M. The position accounts for 0.19% of the portfolio, ranked #90.

Inscription Capital first reported a position in RECS in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.05M in Q4 2025. 175 funds tracked by Wall St. Rank hold RECS as of Q1 2026.

  • Inscription Capital held 46,579 shares of Columbia Research Enhanced Core ETF worth $1.82M as of Q1 2026.
  • Inscription Capital sold 3,568 Columbia Research Enhanced Core ETF shares in Q1 2026, an estimated $145K.
  • Columbia Research Enhanced Core ETF made up 0.19% of Inscription Capital's portfolio in Q1 2026, its #90 holding.
  • Inscription Capital first reported a position in Columbia Research Enhanced Core ETF in Q2 2025 and has held it in 4 quarters since.
  • Inscription Capital's Columbia Research Enhanced Core ETF position peaked at $2.05M in Q4 2025.
  • 175 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q1 2026.

Based on Inscription Capital's 13F filing for Q1 2026, filed 20 Apr 2026.